A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (SunRISe-2)
Urinary Bladder Neoplasms
About this trial
This is an interventional treatment trial for Urinary Bladder Neoplasms
Eligibility Criteria
Inclusion Criteria:
- Ineligible for or have elected not to undergo radical cystectomy
- All adverse events associated with any prior surgery and/or intravesical therapy must have resolved to Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 Grade less than (<) 2 prior to randomization
- Eastern Cooperative Oncology Group (ECOG) performance status Grade 0, 1, or 2
- Thyroid function tests within normal range or stable on hormone supplementation per investigator assessment. Investigators may consult an endocrinologist for participant eligibility assessment in the case of equivocal or marginal test results.
- Adequate bone marrow, liver, and renal function: Bone marrow function (without the support of cytokines or erythropoiesis-stimulating agent in preceding two weeks): Absolute neutrophil count (ANC) greater than or equal to (>=) 1,500/cubic millimeters (mm^3); Platelet count >=80,000/mm^3; Hemoglobin >=9.0 grams per deciliter (g/dL); Liver function: (Total bilirubin less than or equal to (<=) 1.5 * upper limit of normal (ULN) or direct bilirubin <= ULN for participants with total bilirubin levels greater than (>)1.5*ULN (except participants with Gilbert's Syndrome, who must have a total bilirubin < 3.0 mg/dL), and Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) less than or equal to (<=) 2.5* institutional ULN); Renal function: Creatinine clearance >30 mL/min using the Cockcroft-Gault formula.
Exclusion Criteria:
- Must not have had urothelial carcinoma or histological variant at any site outside of the urinary bladder. Ta/T1/Carcinoma in situ (CIS) of the upper urinary tract (including renal pelvis and ureter) is allowable if treated with complete nephroureterectomy more than 24 months prior to initiating study
- Must not have diffuse CIS based on cystoscopy and biopsy. Diffuse, or multi-focal, CIS is defined as the presence of at least 4 distinct CIS lesions in the bladder at the time of the Screening re-TURBT
- Participants must not have evidence of cT4b, or N1-3, or M1 disease based on local radiology staging (chest, abdomen, and pelvis must be performed using Computed tomography [CT] or Magnetic resonance imaging [MRI]) within 42 days prior to randomization
- Presence of any bladder or urethral anatomic feature that, in the opinion of the investigator, may prevent the safe placement, indwelling use, or removal of TAR 200
- Evidence of bladder perforation during diagnostic cystoscopy
Sites / Locations
- University of Southern CaliforniaRecruiting
- Providence Saint John's Health CenterRecruiting
- Stanford University Medical CenterRecruiting
- The Urology Center of Colorado
- Foothills Urology - Golden OffRecruiting
- Winship Cancer Institute of Emory UniversityRecruiting
- DuPage Medical GroupRecruiting
- University Hospitals Seidman Cancer CenterRecruiting
- Adult Pediatric Urology & Urogynecology, P.CRecruiting
- New Jersey Urology LLC
- Cardiology Clinic at Montefiore Hutchinson ComplexRecruiting
- Duke University Medical CenterRecruiting
- Vidant Urology - GreenvilleRecruiting
- Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer CenterRecruiting
- Stephenson Cancer CenterRecruiting
- MidLantic UrologyRecruiting
- Carolina Urologic Research CenterRecruiting
- University of Tennessee Medical CenterRecruiting
- University of Texas Medical BranchRecruiting
- Virginia Oncology AssociatesRecruiting
- Fundacion IntecnusRecruiting
- Sociedade Beneficente de Senhoras - Hospital Sírio LibanêsRecruiting
- Instituto Medico Especializado Alexander FlemingRecruiting
- Hospital Italiano de Buenos AiresRecruiting
- Cemaic - Centro Privado de Especialidades Medicas Ambulatorias e Investigacion ClinicaRecruiting
- Centro Urologico Profesor BengioRecruiting
- Sanatorio Allende CerroRecruiting
- Centro Oncologico Riojano Integral (Cori)Recruiting
- Centro de Investigacion Pergamino SARecruiting
- CEDIC Centro de Investigaciones ClinicasRecruiting
- Flinders Medical Centre
- Krankenhaus der barmherzigen SchwesternRecruiting
- Universitätsklinikum Salzburg - LandeskrankenhausRecruiting
- Medizinische Universität WienRecruiting
- Hopital ErasmeRecruiting
- ZNA MiddelheimRecruiting
- AZ Sint-LucasRecruiting
- AZ Sint-Jan Brugge-Oostende AVRecruiting
- Az Groeninge
- Algemeen Ziekenhuis DeltaRecruiting
- Fundacao Pio XIIRecruiting
- Fundação Hospitalar São Francisco de AssisRecruiting
- Liga Paranaense de Combate ao CancerRecruiting
- Centro Regional Integrado de Oncologia - CRIO
- Clinica de Oncologia ReichowRecruiting
- Fundacao Doutor Amaral CarvalhoRecruiting
- Liga Norte Riograndense Contra O CancerRecruiting
- Hospital das Clinicas de Porto AlegreRecruiting
- União Brasileira de Educação e Assistência-Hospital São Lucas da PUCRSRecruiting
- Hospital Regional do Câncer - Hospital de EsperançaRecruiting
- Hospital Sao RafaelRecruiting
- CEPHO - Centro de Estudos e Pesquisa de Hematologia e OncologiaRecruiting
- Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto - Hospital de BaseRecruiting
- Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao PauloRecruiting
- Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPERecruiting
- Sociedade Beneficente de Senhoras - Hospital Sirio LibanesRecruiting
- Sociedade Beneficente Israelita Brasileira Hospital Albert EinsteinRecruiting
- Centro Oncológico do TriânguloRecruiting
- McGill University Health CentreRecruiting
- CHU de Québec -L'Hôtel-Dieu de QuébecRecruiting
- Chinese Academy of Medical Sciences(CAMS) & Peking Union Medical College(PUMC)Recruiting
- Peking University First HospitalRecruiting
- Peking University Third HospitalRecruiting
- Beijing HospitalRecruiting
- The First Hospital of Jilin UniversityRecruiting
- Hunan Cancer hospitalRecruiting
- The Third Xiangya Hospital of Central Sourth UniversityRecruiting
- West China Hospital of Sichuan UniversityRecruiting
- Chongqing University Cancer HospitalRecruiting
- Guangzhou First Municipal People's HospitalRecruiting
- Sun Yat-Sen University Cancer CenterRecruiting
- Zhejiang Provincial People's HospitalRecruiting
- The First Hospital of JiaxingRecruiting
- Nanjing Drum Tower HospitalRecruiting
- Qingdao Municipal HospitalRecruiting
- Ruijin HospitalRecruiting
- Renji HospitalRecruiting
- Shengjing Hospital of China Medical UniversityRecruiting
- Tianjin Medical University Cancer Institute and HospitalRecruiting
- The First Affiliated Hospital of Wenzhou Medical UniversityRecruiting
- Wuhan Union HospitalRecruiting
- Wuhan Tongji Hospital, Tongji Medical CollegeRecruiting
- Yantai Yuhuangding HospitalRecruiting
- Henan Cancer HospitalRecruiting
- Slezska nemocnice v OpaveRecruiting
- Fakultni nemocnice PlzeRecruiting
- Urocentrum PrahaRecruiting
- Vseobecna fakultni nemocnice v PrazeRecruiting
- Thomayerova nemocnice
- Fakultni nemocnice v MotoleRecruiting
- Nemocnice Na BulovceRecruiting
- Fakultni nemocnice Kralovske VinohradyRecruiting
- ICH Hopital A. MorvanRecruiting
- Pole Sante Leonard de VinciRecruiting
- Clinique Sainte MargueriteRecruiting
- CHRU Lille
- Polyclinique de Limoges - Francois ChenieuxRecruiting
- Hôpital Edouard HerriotRecruiting
- Institut Paoli-CalmettesRecruiting
- Hôpital EuropéenRecruiting
- Institut Regional du Cancer de Montpellier
- CHU NîmesRecruiting
- Hopital Europeen Georges-PompidouRecruiting
- Hôpital Bichat - Claude BernardRecruiting
- Hôpital TenonRecruiting
- Clinical La Croix Du Sud - Ramsay SantéRecruiting
- Centre hospitalier universitaire de St EtienneRecruiting
- Centre Hospitalier PriveRecruiting
- Hopital FochRecruiting
- Urologicum DuisburgRecruiting
- Universitätsklinikum DüsseldorfRecruiting
- Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus KrankenhausRecruiting
- Universitatsklinikum FrankfurtRecruiting
- Klinikum Herne - UrologieRecruiting
- Matthias Schulze - GermanyRecruiting
- Universitätsklinikum MünsterRecruiting
- Klinikum Nürnberg Nord - HautklinikRecruiting
- Alexandra General Hospital of AthensRecruiting
- Metropolitan General A.E.Recruiting
- Athens Medical CenterRecruiting
- Metropolitan HospitalRecruiting
- Bioclinic - ThessalonikiRecruiting
- Euromedica General ClinicRecruiting
- 'Papageorgiou' General Hospital of ThessalonikiRecruiting
- Anassa General ClinicRecruiting
- Orszagos Onkologiai IntezetRecruiting
- Eszak-Pesti Centrumkorhaz - HonvedkorhazRecruiting
- Bajcsy-Zsilinszky Kórház és RendelőintézetRecruiting
- Debreceni Egyetem Klinikai Kozpont
- Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi OktatokorhazRecruiting
- Sujan Surgical Cancer Hospital & Amravati Cancer FoundationRecruiting
- Acharya Tulsi Regional Cancer Treatment Research InstituteRecruiting
- Shatabdi Super Speciality HospitalRecruiting
- BLK Super Specialty HospitalRecruiting
- Aakash Healthcare Super Speciality HospitalRecruiting
- Rajiv Gandhi Cancer Institute & Research CentreRecruiting
- Indira Gandhi Institute of Medical SciencesRecruiting
- Jehangir Clinical Development Center Pvt LtdRecruiting
- Fondazione del Piemonte per I'Oncologia IRCC CandioloRecruiting
- Azienda Ospedaliero Universitaria Ospedali Riuniti di FoggiaRecruiting
- SPDC Villa ScassiRecruiting
- Ospedale San MartinoRecruiting
- Istituto Europeo di OncologiaRecruiting
- Ospedale San RaffaeleRecruiting
- Azienda Ospedaliera Universitaria Federico IIRecruiting
- Istituto Oncologico Veneto - IRCCSRecruiting
- Azienda Sanitaria Locale Salerno - Po Andrea Tortora Di PaganiRecruiting
- Azienda Ospedaliero Universitaria PisanaRecruiting
- ASL Napoli 2 Nord-SM delle Grazie HospitalRecruiting
- Policlinico Universitario Agostino GemelliRecruiting
- Azienda Ospedaliera Sant AndreaRecruiting
- Universita Campus Bio-Medico di RomaRecruiting
- Istituto Nazionale Tumori Regina ElenaRecruiting
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di TorinoRecruiting
- Ospedale di Circolo e Fondazione MacchiRecruiting
- Ospedale San Bortolo
- Aso Co.,Ltd Iizuka HospitalRecruiting
- St.Marianna University HospitalRecruiting
- Nara Medical University HospitalRecruiting
- Saitama Medical University HospitalRecruiting
- Kimitsu Chuo HospitalRecruiting
- Nagasaki University HospitalRecruiting
- JOHAS Osaka Rosai HospitalRecruiting
- Tokuyama Central HospitalRecruiting
- Toranomon HospitalRecruiting
- Fujita Health University HospitalRecruiting
- Yamaguchi University HospitalRecruiting
- Yokohama City University Medical CenterRecruiting
- Inje University Haeundae Paik HospitalRecruiting
- Kyungpook National University Chilgok HospitalRecruiting
- Keimyung University Dongsan HospitalRecruiting
- National Cancer CenterRecruiting
- Gachon University Gil Medical CenterRecruiting
- Seoul National University HospitalRecruiting
- Severance HospitalRecruiting
- Gangnam Severance HospitalRecruiting
- The Catholic University of Korea, Seoul St. Mary's HospitalRecruiting
- Pusan National University Yangsan HospitalRecruiting
- Oncologia Integral SateliteRecruiting
- Consultorio Privado Dr Jose Arturo Rodriguez RiveraRecruiting
- Centro De Estudio Y Prevencion Del CancerRecruiting
- Dr. Marco Antonio Badillo SantoyoRecruiting
- i Can Oncology CenterRecruiting
- Centro de Investigacion Clinica ChapultepecRecruiting
- Oncológico PotosinoRecruiting
- Investigación Biomedica para el desarrollo de Farmacos, S.A. de C.V.Recruiting
- Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II
- Centrum Medyczne Pratia Poznan
- Centralny Szpital Kliniczny MSWiA w Warszawie
- Uniwersytecki Szpital KlinicznyRecruiting
- Centro Hospitalar e Universitario de CoimbraRecruiting
- H. Santa Maria - Centro Hospitalar de Lisboa NorteRecruiting
- Fundação ChampalimaudRecruiting
- Hospital de Sao JoaoRecruiting
- Altlay Regional Oncology Dispensary
- Ivanovo Regional Oncology Dispensary
- Krasnoyarsk Regional Oncology Dispensary
- Hertzen Oncology Research Institute
- A. Tsyb Medical Radiological Research Center
- BHI of Omsk region Clinical Oncology Dispensary
- Ryazan State Medical University named after I.P.Pavlov
- N.N. Petrov Research Institute Of Oncology
- Ogarev Mordovian State University
- State Medical Institution Oncological Center #2 of Healthcare Department at Krasnodar Regio
- Multifunctional clinical medical center 'Medical city'
- Bashkir State Medical University
- Hosp. Univ. A CoruñaRecruiting
- Hosp. Univ. Virgen de Las NievesRecruiting
- Hosp. de Jerez de La FronteraRecruiting
- Clinica Univ. de NavarraRecruiting
- Hosp. Univ. 12 de OctubreRecruiting
- Hosp. Univ. de La PazRecruiting
- Hosp. Univ. Hm SanchinarroRecruiting
- Corporacio Sanitari Parc TauliRecruiting
- Hosp. Univ. Marques de ValdecillaRecruiting
- Instituto Valenciano de OncologiaRecruiting
- Hosp. Clinico Univ. de ValenciaRecruiting
- Kaohsiung Medical University Chung-Ho Memorial HospitalRecruiting
- China Medical University HospitalRecruiting
- Taichung Veterans General HospitalRecruiting
- National Cheng Kung University HospitalRecruiting
- National Taiwan University HospitalRecruiting
- Tri-Service General HospitalRecruiting
- Chang Gung Memorial Hospital Linkou BranchRecruiting
- Adana Baskent Yuregir HospitalRecruiting
- Yildirim Beyazit University Medical Faculty Ankara Atatürk Research and Training HospitalRecruiting
- Ankara Universitesi Tip Fakultesi Cebeci HastanesiRecruiting
- Dokuz Eylul Universitesi Tip FakultesiRecruiting
- Bezmialem University Medical FacultyRecruiting
- Medical Park Gaziantep HastanesiRecruiting
- Istanbul Medeniyet University Goztepe Training and Research HospitalRecruiting
- Izmir Medical Park HospitalRecruiting
- Inonu University Medical FacultyRecruiting
- Erciyes Univ MKD HospitalRecruiting
- T.C. Saglik Bakanligi Ankara Numune Egitim ve Arastirma HastanesiRecruiting
- Chernihivskyi oblasnyi onkolohichnyi dyspanser
- SE Dnipropetrovsk Medical Academy
- Kharkiv Regional Clinical Hospital
- Khersonsky Regional Oncology Center
- Asklepion LLC
- Kyiv City Clinical Hospital #3
- State Institution Academy Of Medical Sciences Of Ukraine
- P.L. Shupyk National Medical Academy of Post-Graduate Education
- Lviv Regional Clinical Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
TAR-200 + Cetrelimab
Chemotherapy (cisplatin or gemcitabine) + Radiation Therapy
Participants will receive intravesical TAR-200 every 3 weeks (21 days indwelling) for first 18 weeks and thereafter from Week 24 every 12 weeks through study Year 3 in combination with intravenous (IV) Cetrelimab.
Participants will receive chemotherapy based on investigator's choice from either cisplatin intravenously once weekly for 6 treatment weeks or gemcitabine intravenously twice weekly for 6 treatment weeks as Standard of Care (SOC) along with radiation therapy from either conventional radiotherapy (64 Gray [Gy], bladder only) for up to 6.5 treatment weeks or hypo-fractionated radiotherapy (55 Gy, bladder only) for up to 4 weeks.